CimCure
An Amsterdam UMC-based biotech spin-off, which focuses on developing vaccine-based cancer immunotherapy
CimCure has raised €5.0M across 1 funding round from 2 investors, most recently a Seed round in Jun 2022. Based in Amsterdam, Netherlands; active in Healthtech. Data as of 28 Oct 2026.
Amsterdam, Netherlandscimcure.com ↗
Total raised
€5.0M
€5,000,000
Funding rounds
1
Investors
2
distinct backers
Active since
2022-06
latest 2022-06
Funding by year
EUR raised per yearCimCure — funding by year — interactive chart.
Data table
| CimCure — funding by year | |
|---|---|
| 2022 | €5.0M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-06-07 | Seed | €5.0M | Positron Ventures,Tom Würdinger | View deal → |
Investors
2Related news
- Dutch cancer vaccine biotech CimCure fetches €5M to shrink a tumor effectivelytechfundingnews.com · 2022-06
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData